Buyer FAQ
Practical answers for skincare brands, clinic/spa suppliers, turnkey partners and distributors evaluating single-dose pilot projects.
Understanding the financial and temporal frameworks for commercial scale-up.
Standard commercial pilot production usually starts from 10,000+ units. This gives your team enough physical units to review filling behavior, pack structure, trial-kit usability, channel feedback and scale-up assumptions. A 5,000-unit review may be possible when the formula, format, channel plan and launch use case are clear enough to justify a smaller first review.
Yes, but 5,000 units are reviewed as an exception, not as the normal market-facing MOQ. A 5,000-unit review is more likely when your formula, launch use case, channel plan and scale-up path are already clear, such as a clinic/spa sample, GWP campaign, travel set, distributor test or turnkey client project that can realistically move toward 10,000+ units.
Yes. If you already have a formula, Steridose Labs can review it under NDA before detailed technical work begins. The review usually checks viscosity, fill-volume target, LDPE compatibility, stability assumptions, appearance standards and package-opening requirements. Some formulas can move forward with limited adjustment, while others need modification before a reliable pilot or commercial review can be planned.
A glass ampoule is usually a rigid, breakable container that can feel premium but may create handling, shipping and travel-kit friction. A BFS LDPE ampoule is formed, filled and sealed in one integrated polymer route. For skincare brands, LDPE BFS is often reviewed as a lighter, non-glass pilot option for GWP, travel sets, trial kits and clinic/spa sample channels.
A useful quotation starts with product type, formula status, target format, target fill volume, intended use case, first pilot quantity, target market, launch timeline and any documentation needs. If you are not sure whether BFS ampoules or liquid-filled swabs fit, describe your current package and what you want the pilot to prove. That is enough for an initial format review.
The first project-fit review begins after a usable brief is received. Response and pilot timing depend on formula readiness, packaging route, sample approval, material planning, production scheduling and any stability or documentation work required. Early-stage buyers can start with a format question first, then move into pilot scoping once the use case is clearer.
Yes. Steridose Labs can support private-label and turnkey beauty partners that want to add BFS LDPE ampoules, small-dose skincare liquids, liquid-filled swabs or pilot-kit modules to brand client projects. The partner can keep the client relationship while Steridose Labs supports format review, formula route, pilot planning and manufacturing-fit discussion behind the project.

Practical questions about formulas, fill volume, ampoules, swab applicators, and packaging behavior.
0.5ml–20ml small-dose skincare liquid projects, depending on format and use case. BFS LDPE ampoule projects are typically reviewed around 0.5ml–10ml, while larger or special formats should be evaluated separately. Final feasibility depends on mold route, formula behavior, opening experience, secondary packaging, unit economics, shelf presentation and your project's launch channel.
BFS LDPE ampoules are usually reviewed for small-dose topical cosmetic and personal-care liquids such as serum, essence, booster, scalp-care liquid, trial-kit liquids, travel-set liquids and professional skincare samples. Suitability depends on viscosity, appearance, compatibility with LDPE, filling behavior, opening design and stability expectations. Formula review is needed before confirming the production route.
Yes. Partner factories and R&D resources can support self-developed skincare liquid concepts, formula adjustment, texture review and project-specific sample work. This is useful for teams that want a turnkey beauty project, private-label route or formula improvement before filling. The final route still depends on formula fit, packaging format, stability work, target market and commercial launch plan.
A liquid-filled swab applicator is a single-use applicator format where liquid and applicator are planned as one pack. Instead of sending a bottle plus loose cotton swab, pad or brush, your team can test a pre-filled route for topical cosmetic or personal-care liquids. It is most useful when the product needs cleaner sampling, clearer instructions and compact kit packing.
Swab applicators are strongest when the product is used in a small controlled area or when your project needs to replace a bottle plus separate applicator routine. Common review routes include scalp-care samples, oral-care sample applicators, pet topical-care applicators, nail/lash/brow liquids, professional beauty care samples and compact channel kits. Final suitability depends on liquid behavior and release mechanism.
Documentation, NDA, quality references, and project-readiness checkpoints for global buyers.
0.5ml–20ml small-dose skincare liquid projects, depending on format and use case. BFS LDPE ampoule projects are typically reviewed around 0.5ml–10ml, while larger or special formats should be evaluated separately. Final feasibility depends on mold route, formula behavior, opening experience, secondary packaging, unit economics, shelf presentation and your project's launch channel.
Initiation
Share the format, liquid type, fill volume, pilot quantity and use case. We can route the brief to BFS ampoule, liquid-filled swab, trial kit, GWP, clinic/spa sample or turnkey planning.